Pre-market
Loading markets…

Advertisement

Stocks

Why Avicanna Inc stock is rising today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:AVCN.TO

Get AVCN alerts:

Photos provided by Pexels

Avicanna Inc's stock surged by 4.17% in the last trading session, reflecting growing investor confidence.

On the TSX, Avicanna Inc (AVCN.TO) saw its stock price increase by 4.17%, closing at CA$0.13. This rise comes amid strategic developments and a growing interest in the cannabinoid healthcare sector, making Avicanna a company to watch.

Advertisement

Avicanna Inc

AVCN.TO

Full stock page →

AVCN.TO

Avicanna Inc

Source:WealthAwesomeWealthAwesome
$0.06 (-32.43%)
120 day period
$0.11$0.15$0.18Mar 10Jun 5Sep 1

Market cap

$17.47M

52W high

$0.30

52W low

$0.10

1W change

-3.85%

Beta

0.33

Analyst Price Targets

Based on analyst covering AVCN

📈

Wall Street analysts forecast AVCN stock price to rise 460.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.70

+460.0% Upside

Current Price

C$0.13

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on AVCN's historical volatility

HistoricalForecast68%95%
C$0.05C$0.10C$0.15C$0.19C$0.24C$0.29TodayApr 23Jun 26Sep 1Oct 14Nov 27Jan 9

30-Day Vol

66.5%

Annualized

90-Day Vol

68.5%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.13

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.13C$0.10C$0.16
60 trading daysC$0.13C$0.09C$0.17
90 trading daysC$0.13C$0.08C$0.19

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors may find Avicanna's recent growth encouraging, especially given its strategic initiatives and the positive market sentiment surrounding cannabinoid healthcare.

4.17% Increase in Stock Price

Avicanna's stock price climbed to CA$0.13, showing a rising interest in its business model and market potential.

Bull case

The recent CDN$300,000 investment from Splash Beverage Group could help Avicanna grow further, potentially leading to more product offerings and a wider market reach. Along with the company's recent financial improvements, this positions Avicanna well for future growth.

Bear case

Despite the positive movement, Avicanna's financials still show a negative profit margin and a relatively small market cap of CA$15.7 million. These factors may raise concerns about its long-term sustainability and ability to compete in a rapidly changing market.

Strategic Investment Boosts Confidence

Advertisement

The CDN$300,000 investment from Splash Beverage Group is expected to strengthen Avicanna's transformation into a leading cannabinoid healthcare platform. This strategic move likely contributes to the positive sentiment surrounding the stock, as investors look forward to further growth and product development.

Financial Improvements Signal Growth Potential

Avicanna has reported significant advancements in its financial performance, including record quarterly revenues and better gross margins. These developments suggest that the company is on a positive path, making it an attractive option for investors interested in the cannabis sector. For more insights, check out Avicanna's financial reports.

Market Sentiment in the Cannabinoid Sector

With the initial U.S. rescheduling of medical cannabis, the market sentiment around cannabinoid companies like Avicanna is becoming increasingly positive. This broader trend may provide additional momentum for Avicanna's stock, as regulatory changes could open new avenues for growth and expansion. For further details, visit the Avicanna stock page.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: June 30, 2026
Last Updated: June 30, 2026
PARTNER SPOTLIGHT

Blue Cross Life® Term Life Insurance

Affordable term life coverage in Canada — get a free quote in seconds, no credit card required.

  • Coverage from $100,000 to $5 million, terms of 10–30 years
  • 10% off first-year premiums when couples apply together
  • Fully digital application — many qualify without a medical exam

Sponsored links

Advertisement